Amanote Research
Register
Sign In
Psy1 - Risk of Liver Enzyme Elevation in Autoimmune Patients With Different Hepatitis B Virus Infection Status Receiving Biologic Agents
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.2578
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
Y. Chiu
Publisher
Elsevier BV
Related search
Reactivation of Hepatitis B Virus in Rheumatologic Patients Receiving Immunosuppressive Agents
Digestive Diseases and Sciences
Physiology
Gastroenterology
Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis
Annals of Transplantation
Medicine
Transplantation
Occult Hepatitis B Infection in Different High Risk Patients
Hepatitis Monthly
Hepatology
Infectious Diseases
Prevalence of Hepatitis B Virus Infection Among Alcoholic Patients With Liver Disease.
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
FRI0181 Tapering or Cessation of Antiviral Agent in Hepatitis B Virus-Infected Patients Concomitantly Treated With Biologic Agents
Hepatitis B Virus Infection and the Risk of Liver Disease Progression in Type 2 Diabetic Patients With Potential Nonalcoholic Fatty Liver Disease
European Journal of Gastroenterology and Hepatology
Hepatology
Gastroenterology
Molecular Characterization of Occult Hepatitis B Virus Infection in Patients With End-Stage Liver Disease in Colombia
PLoS ONE
Multidisciplinary
Statin and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus or Hepatitis C Virus Infection: A Meta-Analysis
BMC Gastroenterology
Medicine
Gastroenterology
Telbivudine (Sebivo) in Patients With Hepatitis B Virus (HBV) Chronic Infection
Farmeconomia. Health economics and therapeutic pathways
